TF and plasma cell myeloma: In a retrospective study of 5259 patients with multiple myeloma (MM) at the University of Arkansas, we identified adverse prognostic factors, including delayed MM-diagnosis-to-ASCT duration, high serum ferritin, and low transferrin levels.